We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
+15.19%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$405M
AUM Growth
+$44M
Cap. Flow
-$9.18M
Cap. Flow %
-2.27%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
2
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$8.09M
2
VVUS
Vivus Inc
VVUS
+$1.09M

Sector Composition

Rank Sector Weight
1 Healthcare 93.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$321M 79.15%
21,509,713
-560,500
-3% -$8.09M
ALKS icon
2
Alkermes
ALKS
$8.82B
$57.3M 14.14%
1,030,639
EPI icon
3
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$13.5M 3.34%
670,000
INDA icon
4
iShares MSCI India ETF
INDA
$6.71B
$12.9M 3.18%
480,000
VVUS
5
DELISTED
Vivus Inc
VVUS
$792K 0.2%
68,850
-91,150
-57% -$1.09M

Similar funds

Meditor Group's Q4 2016 Portfolio in Review

As of Q4 2016, Meditor Group held 5 positions worth $405M, up 12% from $361M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2016: portfolio turnover was 0%. Meditor Group opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 92% a quarter earlier.

  • Meditor Group's biggest Q4 2016 reduction was Exelixis, cutting an estimated $8.09M.
  • Meditor Group's ten largest holdings make up 100% of its $405M portfolio in Q4 2016.
  • Meditor Group opened 0 new positions and closed 0 in Q4 2016.
  • Meditor Group's portfolio value rose 12% quarter-over-quarter to $405M.

Based on Meditor Group's 13F filing for Q4 2016, filed 1 Feb 2017.